Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Exchange Rate Effect: 2009-2025

Historic Exchange Rate Effect for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to -$1.2 million.

  • BIO-TECHNE's Exchange Rate Effect fell 123.66% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year decrease of 51.18%. This contributed to the annual value of $11.9 million for FY2025, which is 611.23% up from last year.
  • Per BIO-TECHNE's latest filing, its Exchange Rate Effect stood at -$1.2 million for Q3 2025, which was down 109.06% from $13.4 million recorded in Q2 2025.
  • BIO-TECHNE's 5-year Exchange Rate Effect high stood at $13.4 million for Q2 2025, and its period low was -$11.9 million during Q3 2022.
  • In the last 3 years, BIO-TECHNE's Exchange Rate Effect had a median value of -$1.1 million in 2025 and averaged $870,909.
  • In the last 5 years, BIO-TECHNE's Exchange Rate Effect tumbled by 4,548.67% in 2022 and then soared by 569.18% in 2024.
  • Over the past 5 years, BIO-TECHNE's Exchange Rate Effect (Quarterly) stood at $3.1 million in 2021, then soared by 138.86% to $7.3 million in 2022, then tumbled by 53.40% to $3.4 million in 2023, then slumped by 259.74% to -$5.5 million in 2024, then plummeted by 123.66% to -$1.2 million in 2025.
  • Its last three reported values are -$1.2 million in Q3 2025, $13.4 million for Q2 2025, and -$1.1 million during Q1 2025.